Craig W. Davis

1.2k total citations
31 papers, 1.0k citations indexed

About

Craig W. Davis is a scholar working on Molecular Biology, Cognitive Neuroscience and Physiology. According to data from OpenAlex, Craig W. Davis has authored 31 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Cognitive Neuroscience and 5 papers in Physiology. Recurrent topics in Craig W. Davis's work include Phosphodiesterase function and regulation (10 papers), Sleep and Wakefulness Research (8 papers) and Enzyme function and inhibition (5 papers). Craig W. Davis is often cited by papers focused on Phosphodiesterase function and regulation (10 papers), Sleep and Wakefulness Research (8 papers) and Enzyme function and inhibition (5 papers). Craig W. Davis collaborates with scholars based in United States, France and Germany. Craig W. Davis's co-authors include John W. Daly, J.F. Kuo, Jack N. Wells, E P Nace, Mikio Shoji, David Smelson, Miklos Losonczy, Douglas Ziedonis, John Williams and Virginia L. Seery and has published in prestigious journals such as Nature, Journal of Biological Chemistry and American Journal of Psychiatry.

In The Last Decade

Craig W. Davis

30 papers receiving 912 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Craig W. Davis United States 15 457 212 166 155 142 31 1.0k
Ethan Hoffmann United States 22 599 1.3× 353 1.7× 146 0.9× 107 0.7× 100 0.7× 33 2.1k
Frederick J. Marshall United States 26 445 1.0× 406 1.9× 114 0.7× 30 0.2× 57 0.4× 72 1.9k
Salvador Sierra United States 17 277 0.6× 505 2.4× 61 0.4× 165 1.1× 36 0.3× 27 935
Cosima Rhein Germany 14 595 1.3× 124 0.6× 72 0.4× 32 0.2× 76 0.5× 32 1.1k
Letizia Polito Italy 21 319 0.7× 151 0.7× 116 0.7× 21 0.1× 47 0.3× 45 1.3k
Ernst A. Singer Austria 23 747 1.6× 938 4.4× 88 0.5× 71 0.5× 35 0.2× 42 1.5k
Hongmei Cao China 15 262 0.6× 129 0.6× 48 0.3× 41 0.3× 29 0.2× 36 1.1k
Markus Piel Germany 21 270 0.6× 302 1.4× 211 1.3× 35 0.2× 16 0.1× 51 1.2k
Michael A. Ackley United States 13 287 0.6× 401 1.9× 89 0.5× 25 0.2× 207 1.5× 22 859
Karen Benwell United Kingdom 13 401 0.9× 493 2.3× 53 0.3× 101 0.7× 55 0.4× 16 909

Countries citing papers authored by Craig W. Davis

Since Specialization
Citations

This map shows the geographic impact of Craig W. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig W. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig W. Davis more than expected).

Fields of papers citing papers by Craig W. Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig W. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig W. Davis. The network helps show where Craig W. Davis may publish in the future.

Co-authorship network of co-authors of Craig W. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Craig W. Davis. A scholar is included among the top collaborators of Craig W. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig W. Davis. Craig W. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kallweit, Ulf, et al.. (2021). Pitolisant for the treatment of cataplexy in adults with narcolepsy. Expert Opinion on Orphan Drugs. 9(11-12). 237–246. 2 indexed citations
2.
3.
4.
Davis, Craig W., Ulf Kallweit, J. Schwartz, et al.. (2021). Efficacy of pitolisant in patients with high burden of narcolepsy symptoms: pooled analysis of short-term, placebo-controlled studies. Sleep Medicine. 81. 210–217. 9 indexed citations
5.
Smelson, David, Craig W. Davis, Norman Eisenstein, et al.. (2003). Cognitive disparity in schizophrenics with and without cocaine dependency. Journal of Substance Abuse Treatment. 24(1). 75–79. 16 indexed citations
6.
Smelson, David, et al.. (2002). Executive and Motor Skill Functioning among Cocaine-Dependent Schizophrenics and Non–Drug-Abusing Schizophrenics. The Journal of Nervous and Mental Disease. 190(3). 200–202. 14 indexed citations
7.
Smelson, David, et al.. (2002). Risperidone Decreases Craving and Relapses in Individuals with Schizophrenia and Cocaine Dependence. The Canadian Journal of Psychiatry. 47(7). 671–675. 84 indexed citations
8.
Dunn, Bruce E., Hongyung Choi, Urias A. Almagro, Daniel L. Recla, & Craig W. Davis. (2000). Telepathology Networking in VISN-12 of the Veterans Health Administration. Telemedicine Journal and e-Health. 6(3). 349–354. 39 indexed citations
9.
Davis, Craig W., et al.. (1991). The Importance of Street Drug Terms as Diagnostic Clues. Journal of Health & Social Policy. 3(1). 45–53. 1 indexed citations
10.
Davis, Craig W.. (1985). Regulation of adenosine 3′:5′-monophosphate-dependent protein kinase in cerebral cortex. Life Sciences. 37(1). 85–94. 2 indexed citations
11.
Davis, Craig W., et al.. (1984). 1-(4-Aminophenyl)isoquinoline derivatives. Biochemical Pharmacology. 33(8). 1205–1212. 3 indexed citations
12.
Stubbins, James F., et al.. (1983). 1-(4-Aminobenzyl)- and 1-(4-aminophenyl)isoquinoline derivatives: synthesis and evaluation as potential irreversible cyclic nucleotide phosphodiesterase inhibitors. Journal of Medicinal Chemistry. 26(2). 174–181. 15 indexed citations
13.
Davis, Craig W.. (1982). Selective alteration of Ca+ -dependent and Ca2+ -independent cyclic nucleotide phosphodiesterase activity in rat cerebral cortex by cyclic nucleotides and their analogs. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 705(1). 1–7. 1 indexed citations
14.
Davis, Craig W. & John W. Daly. (1980). Activation of Rat Cerebral Cortical 3',5'-Cyclic Nucleotide Phosphodiesterase Activity by Gangliosides. Molecular Pharmacology. 17(2). 206–211. 57 indexed citations
15.
Davis, Craig W., et al.. (1979). Alkylxanthines: Inhibition of adenosine-elicited accumulation of cyclic AMP in brain slices and of brain phosphodiesterase activity. Life Sciences. 24(26). 2475–2481. 270 indexed citations
16.
Davis, Craig W. & John W. Daly. (1978). Calcium-dependent 3‘:5‘-cyclic nucleotide phosphodiesterase. Inhibition of basal activity at physiological levels of potassium ions.. Journal of Biological Chemistry. 253(24). 8683–8686. 26 indexed citations
17.
Shoji, Mamoru, Harold P. Morris, Craig W. Davis, Nancy L. Brackett, & J.F. Kuo. (1977). Modified cyclic nucleotide systems in Morris hepatoma 3924A favoring expression of cyclic GMP effect. Biochimica et Biophysica Acta (BBA) - General Subjects. 500(2). 419–424. 14 indexed citations
18.
Shoji, Mikio, et al.. (1977). Guanosine cyclic monophosphate-dependent protein kinase from foetal calf heart. Purification, general properties and catalytic subunit. Biochemical Journal. 161(2). 213–221. 42 indexed citations
19.
20.
Kuo, J.F., Craig W. Davis, & James Tse. (1976). Depressed cardiac cyclic GMP-dependent protein kinase in spontaneously hypertensive rats and its further depression by guanethidine. Nature. 261(5558). 335–336. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ethan Hoffmann Breakdown of academic impact, for papers by Frederick J. Marshall Breakdown of academic impact, for papers by Salvador Sierra Breakdown of academic impact, for papers by Cosima Rhein Breakdown of academic impact, for papers by Letizia Polito Breakdown of academic impact, for papers by Ernst A. Singer Breakdown of academic impact, for papers by Hongmei Cao Breakdown of academic impact, for papers by Markus Piel Breakdown of academic impact, for papers by Michael A. Ackley Breakdown of academic impact, for papers by Karen Benwell
Rankless by CCL
2026